Biosafety Laboratory Facility (BSL)-3

Welcome!

Following the COVID-19 epidemics, we have secured funding from the Brazilian Scientific Research Council (CNPq) to develop a novel BCG-based SARS-Cov-2 vaccine. We are happy to inform the scientific community that the construction of our BSL-3 facility has been initiated.